Novo Nordisk’s weight-loss drug Wegovy launches in PHL
Global healthcare company Novo Nordisk on Friday launched a new semaglutide-based medication in the country, positioning it to help Filipinos with obesity or who are overweight man...
Search fresh public links, source activity, and post angles for Wegovy.
Fresh curated links around Wegovy are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Global healthcare company Novo Nordisk on Friday launched a new semaglutide-based medication in the country, positioning it to help Filipinos with obesity or who are overweight man...
THURSDAY, April 2, 2026 — A popular weight loss drug may soon be more affordable for some people. Danish pharmaceutical company Novo Nordisk has launched a subscription program for...
What You Should Know The Launch: GoodRx has announced it is now offering Wegovy HD—Novo Nordisk’s newly introduced, higher-dose (7.2 mg) semaglutide injection. The Price Point: In...
Alongside the $399 monthly dose, patients can choose to get a two-month supply for $798 or a three-month supply for $1,197.
Wegovy® showed an average 22.6% weight loss for premenopausal women with obesity, with more than 4 in 10 (41.4%) achieving 25% or more weight loss¹. Substantial weight loss was con...
Novo Nordisk launched its Wegovy pill in January as it fought back against Eli Lilly, the maker of rival drug Mounjaro, after seeing sales and profits tumble.
Sales are booming for Novo Nordisk’s new weight-loss pill. In its first earnings report since the release of an alternative to its hit GLP-1 shot, Novo Nordisk’s outlook is loo...
In its latest earnings report, the Danish drugmaker said sales and profit should shrink less than the company originally anticipated thanks to strong prescription numbers for its n...
The GLP-1 subscription program is available to eligible self-pay patients through select telehealth providers, including Ro, WeightWatchers and Him & Hers.
Amazon launched a new program aimed at expanding access to popular GLP-1 weight-loss drugs like Wegovy.
Survodutide spurred weight loss Wall Street analysts referred to as “Wegovy-like,” and showed signs it might help preserve muscle mass as well.
Novo Nordisk on Wednesday narrowly improved its financial guidance for a year where it still sees profit and sales falling after the fastest take-up in weight-loss drug history for...
Currently unfunded, Wegovy would cost someone about $400 a month.
Plans to file with the Indian regulator too, seeking approvals for the higher dose
Pharmac has put Wegovy on its list of medicines suitable for future funding.
The U.S. Food and Drug Administration on Wednesday approved Eli Lilly's weight-loss pill, making it the second to market after Novo Nordisk's oral Wegovy, as the companies fight to...
This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, resulted in an average of 27 pounds lost in 72 weeks
Eli Lilly announced clinical trial results for retatrutide, its next gen obesity drug. The drug helped study participants lose 70 lbs over 80 weeks, making it more powerful than Ze...
Foundayo could erase the Wegovy pill’s four-month head start as the two drugmakers clash on a debate of efficacy and convenience.
Weekly injection semaglutide - sold under brand names Wegovy and Ozempic - helped addicts cut number of heavy drinking days each month
A major new analysis suggests semaglutide (Ozempic, Wegovy) works remarkably well in adults over 65, helping many lose substantial amounts of weight while improving heart and metab...
The GLP-1 market is growing fast. Here’s how much the most popular medications will cost you.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.